Inside Drug Pricing - 04/08/2019

Top Insulin Makers, PBMs To Testify At E&C Insulin Pricing Hearing

April 02, 2019
Updated Story Representatives for top insulin makers and pharmacy benefit managers will testify at an upcoming House Energy & Commerce subcommittee hearing on rising insulin prices next week , Oversight & investigations subcommittee Chair Rep. Diana DeGette (D-CO) said Tuesday (April 2). Eli Lilly, Sanofi, Novo Nordisk, Express Scripts, CVS and OptumRx are confirmed to appear. “We are committed to ensuring everyone living with diabetes has reasonable access to insulin, and we appreciate Congressional interest in this...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.